Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) ...

Detailed price information for Aclarion Inc WT (ACONW-Q) from The Globe and Mail including charting and trades.

Inc trading halted, volatility trading pauseDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Inc trading resumesDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company specializing in chronic low back pain diagnosis, with a current market capitalization of $7.11 million ...

BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...

Aclarion, Inc., a medical laboratories services provider, announced the approval of key proposals by its shareholders during a Special Meeting held on Tuesday. The meeting, which was initially set ...

Aclarion, Inc., a healthcare technology company specializing in chronic low back pain solutions, announced plans to expand access to its Nociscan service in New York and New Jersey, building on ...

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented ...

Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan ...